Hannah Valantine, Director: BridgeBio Pharma BBIO Sell · Filed 25/03/10

Trade details

Type: Insider sale
Amount: $419,467.5
Shares · price: 12,875 sh · $32.58 a share
Held after: 1,764 sh
Stock: BridgeBio Pharma BBIO
Person: Hannah ValantineDirector
Trade date: 25/03/06
Filed: 25/03/10
Days to filing: 4 days

Sold 87.9% of holdings

Share of holding sold: 87.9%

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 25/02/04~25/04/05

Hannah Valantine's recent trades

Hannah ValantineDirector
Planned sale10b5-1 planCareDx
Planned sale10b5-1 plan
CareDx
CDNA
$856.2K
28,779 sh
$856.2K
Filed 07/16
Traded 07/16
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/24
Traded 06/22
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/24
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/23
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/22
Traded 06/22